
Kuftreat AT Expectorant
Marketer
Ess Emm Pharma Pvt Ltd
Salt Composition
Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml)
Overview Kuftreat AT Expectorant
Respifree Cough Relief is a multi-ingredient formulation for cough management. It works by loosening thick mucus in the airways, facilitating easier expulsion. This medication also soothes throat discomfort and offers a cooling effect. Respifree Cough Relief should be taken as directed by your physician, with or without food, for the prescribed duration. Dosage is individualized based on your health status and response. Complete the full course of treatment; premature discontinuation may lead to symptom recurrence and potential worsening of your condition. Inform your doctor of all other medications you are currently using, as interactions are possible. Common side effects include nausea, diarrhea, vomiting, abdominal pain, headache, skin rash, trembling, and elevated heart rate. Most are transient and self-limiting. Report any concerning side effects to your doctor immediately. Drowsiness may occur; avoid driving or activities requiring alertness until its effects on you are known. Alcohol consumption should be avoided due to potential increased drowsiness. Never self-medicate or share your prescription. Adequate hydration is recommended while using this medication. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment.
Primary Ingredients of Kuftreat AT Expectorant
The provided text is "undefined," so no rephrasing is possible.
Uses of Kuftreat AT Expectorant
Respiratory irritation
Major Benefits of Kuftreat AT Expectorant:
Administer this medication according to your physician's prescribed dosage and schedule. Always refer to the product label for instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Kuftreat AT Expectorant can be consumed with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Kuftreat AT Expectorant:
- Nausea
- Diarrhea
- Vomiting
- Dizziness
- Headache
- Rash
- Tremors
- Increased heart rate
- Upper abdominal pain
- Urticaria
- Itching
- Sweating
- Changes in serum aminotransferase levels
- Bloating
- Indigestion
How to use Kuftreat AT Expectorant:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Always consult the product label for complete instructions prior to use. Accurate measurement should be achieved using a calibrated measuring device; ingest orally. Ensure thorough shaking before each administration. Kuftreat AT Expectorant can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Kuftreat AT Expectorant works:
Ambroxol, guaifenesin, menthol, and terbutaline are the four active components of the expectorant medication, Kuftreat AT.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kuftreat AT Expectorant may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Kuftreat AT Expectorant during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Kuftreat AT Expectorant with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Kuftreat AT Expectorant on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Kuftreat AT Expectorant appears safe for individuals with kidney conditions. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Kuftreat AT Expectorant in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Kuftreat AT Expectorant :
NA
Facts to Know About Kuftreat AT Expectorant
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
